Mostrar el registro sencillo del ítem

dc.contributor.authorBritto Rivera, Mitzy
dc.contributor.authorMórelo Espitia, Gleymer
dc.contributor.authorRomero Martínez, Vanessa
dc.date.accessioned2020-01-15T17:00:33Z
dc.date.available2020-01-15T17:00:33Z
dc.date.issued2019
dc.identifier.urihttps://hdl.handle.net/20.500.12442/4515
dc.description.abstractIntroducción: La coinfección entre el Virus de Hepatitis B-VHB y el Virus de Inmunodeficiencia Humana-VIH es un evento que se puede presentar en pacientes con determinadas características según diversos estudios relacionados. Su incidencia es variada, pero no muy conocida en el país y en la costa caribe de Colombia. Objetivo: Dado lo anterior se determinó caracterizar y determinar la incidencia de coinfección entre VIH/VHB en la población adulta atendida en la Clínica de la Costa en la ciudad de Barranquilla en el periodo comprendido de 01 de Enero de 2.010 a 31 de Diciembre de 2017.spa
dc.description.abstractIntroduction: Co-infection between Hepatitis B-HBV Virus and Human Immunodeficiency Virus-HIV is an event that can occur in patients with certain characteristics according to various related studies. Its incidence is varied, but not well known in the country and on the Caribbean coast of Colombia. Objective: Given the above, it was determined to characterize and determine the incidence of HIV / HBV co-infection in the adult population treated at the Costa Clinic in the city of Barranquilla in the period from January 1, 2010 to December 31, 2017.eng
dc.format.mimetypepdfspa
dc.language.isospaspa
dc.publisherEdiciones Universidad Simón Bolívarspa
dc.publisherFacultad de Ciencias de la Saludspa
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectInfecciones por VIHspa
dc.subjectCoinfecciónspa
dc.subjectHepatitis Bspa
dc.subjectInfecciones oportunistas relacionadas con el SIDAspa
dc.subjectVIH infectionseng
dc.subjectCoinfectioneng
dc.subjectAIDS-Related Opportunistic Infectionseng
dc.titleCo infección por Virus de Inmunodeficiencia Humana y Hepatitis B en una Clínica de Alta Complejidad de Barranquilla 2010 2017spa
dc.typeOtherspa
dcterms.referencesSalud. O-OM de la. Hepatitis B. Notas descriptivas. Cent prensa [Internet]. 2018; Available from: https://www.who.int/es/news-room/fact-sheets/detail/hepatitis-Bspa
dcterms.referencesONUSIDA. Últimas estadísticas sobre el estado de la epidemia de sida. Cent Prensa [Internet]. 2018; Available from: https://www.unaids.org/es/resources/fact-sheetspa
dcterms.referencesMandell D y B. Enfermedades infecciosas. Principios y práctica. 8th ed. Elsevier. Elsevier; 2016.spa
dcterms.referencesBivigou-Mboumba B, Amougou-Atsama M, Zoa-Assoumou S, M’boyis Kamdem H, Nzengui-Nzengui GF, Ndojyi-Mbiguino A, Njouom R F-SS. Hepatitis B infection among HIV infected individuals in Gabon: Occult hepatitis B enhances HBV DNA prevalence. PLoS One. 2018;13(1):e0190592.eng
dcterms.referencesMertens TE L-BD. HIV and AIDS: Where is the epidemic going? World Heal Organ. 2010;74(2):121–9.eng
dcterms.referencesSoza A. Coinfección de hepatitis B y C con VIH. Medwave. 2007;5:3324.spa
dcterms.referencesSalud. M de S-IN de. Hepatitis B, C y Coinfección/Superinfección hepatitis B-Delta. Protocolo de Vigilancia en Salud Pública. Bogotá; 2017.spa
dcterms.referencesAgyeman AA O-AR. Prevalence of HIV and hepatitis B coinfection in Ghana: a systematic review and meta-analysis. AIDS Res Ther [Internet]. 2016;13:23. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4869330&tool=pmcentrez&rendertype=abstracteng
dcterms.referencesCL T. Hepatitis B and human immunodeficiency virus coinfection. Hepatology. 2010;49(5):17360–7.eng
dcterms.referencesBerger A, Preiser W DH. The role of viral load determination for the management of human immunodeficiency virus, hepatitis B virus and hepatitis C virus infection. j Clin Vir [Internet]. 2011;20:23–30. Available from: http://www.sciencedirect.com/science/article/pii/S1386653200001517eng
dcterms.referencesBobek V, Kolostova K, Pinterova D, Kacprzak G, Adamiak J, Kolodziej J et al. A clinically relevant, syngeneic model of spontaneous, highly metastatic B16 mouse melanoma. Anticancer Res. 2010;30(12):4799–804.eng
dcterms.referencesOliveira SB de, Merchán-Hamann E AL. HIV/AIDS coinfection with the hepatitis B and C viruses in Brazil. Cad sau pub. 2014;30(2):433–8.eng
dcterms.referencesS C. Collection S. HHS Public Access. 2016;8(5):583–92.eng
dcterms.referencesM. L-B. Coinfección de hepatitis B e infección por VIH. Ac Med Col. 2008;50(3):50–3.spa
dcterms.referencesDe La Hoz JM, Bolaño L, Cárdenas O, González R, Sabbag J, Palacio L et al. Characterization of treatment failure in HIV positive patients in the Colombian Caribbean region. Col Med. 2014;eng
dcterms.referencesPuglia M, Stasi C VF. Prevalence and characteristics of HIV/HBV and HIV/HCV coinfections in Tuscany. Bra J Inf Dis. 2016;20(4):330–4.eng
dcterms.referencesMallet V, Hamed K SM. Prognosis of Patients with Chronic Hepatitis B in France (2008-2013): A Nationwide, Observational and Hospital-based Study. J Hepatol [Internet]. 2016; Available from: http://linkinghub.elsevier.com/retrieve/pii/S0168827816306420eng
dcterms.referencesBautista-Amorocho H, Castellanos-Domínguez YZ, Rodríguez-Villamizar LA, Velandia-Cruz SA, Becerra-Peña JA F-GA. Epidemiology, risk factors and genotypes of HBV in HIV-infected patients in the northeast region of Colombia: High prevalence of occult hepatitis B and F3 subgenotype dominance. PLoS One. 2014;9(12):1–14.eng
dcterms.referencesUNAIDS. Global-SIDA-update-2016. UNAIDS [Internet]. 2016; Available from: http://www.unaids.org/sites/default/files/media_asset/globalSIDA-update-2016_en.pdf.eng
dcterms.referencesRuiz P, Téllez-Molina MJ, Vergas-García J, Altali-Alhames K F-CA. Coinfección por VIH/VHB: estrategias terapéuticas y control serológico. Rev Clin Esp. 2103;spa
dcterms.referencesL M. Interacciones entre el virus de la hepatitis y el VIH. Lancet Infect Dis. 2014;14(11):1025–7.spa
dcterms.referencesPolo P, Castañeda C, Sierra M AN. Occult Hepatitis B co-infection in health center patients with HIV in Vitalsalud IPS Barranquilla, Colombia. Programa Integr Atención del VIH Univ Cart Grup Investig en Econ la Salud. 2010;eng
dcterms.referencesTobón-Pereira JC T-MA. Study of the patient with HIV infection. Med Lab. 2008;14(11):20.eng
dcterms.referencesYeom JS, Jun G, Chang Y, Sohn MJ, Yoo S, Kim E et al. Evaluation of a new fourth generation enzyme-linked immunosorbent assay, the LG HIV Ag-Ab Plus, with a combined HIV p24 antigen and anti-HIV-1/2/O screening test. J Virol Methods. 206AD;137:292–7.eng
dcterms.referencesYeom JS, Lee JB, Ryu SH, Kang HJ, Kim S, Kim YA et al. No TitleEvaluation of a new third-generation ELISA for the detection of HIV infection. Ann Clin Lab Sci. 2006;36:73–8.eng
dcterms.referencesL. G. Difficulties and strategies of HIV diagnosis. Lancet. 1996;348:176–9.eng
dcterms.referencesDeSimone JA PR. New methods for the detection of HIV. Clin Lab Med. 2002;22:573–92.eng
dcterms.referencesKimmel AD, Losina E, Freedberg KA GS. Diagnostic tests in HIV management: a review of clinical and laboratory strategies to monitor HIV-infected individuals in developing countries. No Title. Bull World Heal Organ. 2006;84:581–8.eng
dcterms.referencesSchupbach J, Boni J, Flepp M, Tomasik Z JH, M. O. Antiretroviral treatment monitoring with an improved HIV-1 p24 antigen test: an inexpensive alternative to tests for viral RNA. J Med Virol. 2001;65:225–32.eng
dcterms.referencesMontoro MA GJ. Problemas comunes en la práctica clínica. Jarpyo Editores, editor. Gastroenterologia y Hepatologia. 2012.spa
dcterms.referencesPiroth L, Sene D, Pol S, Goderel I, Lacombe K MB, Al. E. Epidemiology, diagnosis and treatment of chronic hepatitis B in HIV-infected patients (EPIB 2005 STUDY). AIDS. 2007;21: 1323–31.eng
dcterms.referencesManegold C, Hannoun C, Wywiol A, Dietrich M PS, Chiwakata CB et al. Reactivation of hepatitis B virus replication accompanied by acute hepatitis in patients receiving highly active antiretroviral therapy. Clin Infect Dis. 2001; 32: 144– 8.eng
dcterms.referencesMinisterio de Salud y Protección Social de Colombia. Ley 100. Bogotá; 1993.spa
dcterms.referencesMinisterio de Salud y Protección Social de Colombia. Ley 715. Bogotá; 2001.spa
dcterms.referencesMinisterio de Salud y Protección Social de Colombia. Ley 1098. Bogotá; 2006.spa
dcterms.referencesMinisterio de Salud y Protección Social de Colombia. Ley 972. Bogotá; 2005.spa
dcterms.referencesMinisterio de Salud y Protección Social de Colombia. Decreto 2323. Bogotá; 2006.spa
dcterms.referencesMinisterio de Salud y Protección Social de Colombia. Decreto 3518. Bogotá; 2006.spa
dcterms.referencesMinisterio de Salud y Protección Social de Colombia. Decreto 1543. Bogotá; 1997.spa
dcterms.referencesMinisterio de Salud y Protección Social de Colombia. Resolución 3442. Bogotá; 2006.spa
dcterms.referencesM. G-D. Rapid Initiation of Antiretroviral Therapy after HIV Diagnosis. AIDS Rev. 2019;21(2):55–64.eng
dcterms.referencesFrempong MT, Ntiamoah P, Annani-Akollor ME, Owiredu WKBA, Addai-Mensah O, Owiredu EW, Adu-Gyasi D, Agyapong EO SL. Hepatitis B and C infections in HIV-1 and non-HIV infected pregnant women in the Brong-Ahafo Region, Ghana. PLoS One. 2019;14(7):e0219922.eng
dcterms.referencesHashiani AA, Sadeghi F, Ayubi E, Rezaeian S, Moradi Y, Mansori K, Gholamaliei B, Mohammadbeigi A KS. Prevalence of HIV, Hepatitis B and C Virus Co-infections among Iranian High-Risk Groups: A Systematic Review and Meta-Analysis. Malays J Med Sci. 2019;26(3):37–48.eng
dcterms.referencesMcKee G, Butt ZA, Wong S, Salway T, Gilbert M, Wong J, Alvarez M, Chapinal N, Darvishian M, Tyndall MW, Krajden M JN. Syndemic Characterization of HCV, HBV, and HIV Co-infections in a Large Population Based Cohort Study. EClinicalMedicine. 2018;4(5):99–108.eng
dcterms.referencesAltawalah H, Essa S, Ezzikouri S A-NW. Hepatitis B virus, hepatitis C virus and human immunodeficiency virus infections among people who inject drugs in Kuwait: A cross-sectional study. Sci Rep. 2019;9(1):6292.eng
dcterms.referencesScheibe A, Young K, Moses L, Basson RL, Versfeld A, Spearman CW, Sonderup MW, Prabdial-Sing N, Manamela J, Puren AJ, Rebe K HH. Understanding hepatitis B, hepatitis C and HIV among people who inject drugs in South Africa: findings from a three-city cross-sectional survey. Harm Reduct J. 2019;16(1):28.eng
dcterms.referencesOmatola CA, Lawal C, Omosayin DO, Okolo MO, Adaji DM, Mofolorunsho CK BK. Seroprevalence of HBV, HCV, and HIV and Associated Risk Factors Among Apparently Healthy Pregnant Women in Anyigba, Nigeria. Viir immu. 2019;32(4):183–91.eng
dcterms.referencesOpaleye OO, Igboama MC, Ojo JA OG. Seroprevalence of HIV, HBV, HCV, and HTLV among Pregnant Women in Southwestern Nigeria. Immu Immu. 2016;37(1):29–42.eng
dcterms.referencesRamos JM, Toro C, Reyes F, Amor A GF. Seroprevalence of HIV-1, HBV, HTLV-1 and Treponema pallidum among pregnant women in a rural hospital in Southern Ethiopia. J Clin Virol. 2011;51(1):83–5.eng
dcterms.referencesHepatitis B. In: Pathologie Biologie. Elsevier Masson; 2011. p. 243–314.eng
dcterms.referencesDesikan P KZ. Prevalence of hepatitis B and hepatitis C virus co-infection in India: A systematic review and meta-analysis. Indian J Med Microbiol. 2017;35:332–9.eng
dcterms.referencesSIVIGILA. S de VE. Boletín Epidemiológico Semana 52. Programa de VIH-Barranquilla. 2018.spa
dcterms.referencesSalud. IN de. Boletín Epidemiológico Semana 47 [Internet]. Bogotá; 2018. Available from: https://www.ins.gov.co/buscador-eventos/BoletinEpidemiologico/2018 Boletín epidemiológico semana 47.pdf.spa
dcterms.referencesMutagoma M, Balisanga H, Malamba SS, Sebuhoro D, Remera E, Riedel DJ, Kanters S NS. Hepatitis B virus and HIV co-infection among pregnant women in Rwanda. BMC Infect Dis. 2017;17(1):18.eng
sb.sedeSede Barranquillaspa
sb.programaEspecialización en Medicina Internaspa
dc.rights.accessrightsinfo:eu-repo/semantics/restrictedAccessspa
oaire.versioninfo:eu-repo/semantics/submittedVersionspa


Ficheros en el ítem

Thumbnail
Thumbnail
Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Attribution-NonCommercial-NoDerivatives 4.0 Internacional